히알루론산 시장 규모, 점유율, 동향 분석 보고서 : 용도별, 지역별, 부문별 예측(2026-2033년)

Hyaluronic Acid Market Summary

The global hyaluronic acid market size was estimated at USD 11.50 billion in 2025 and is projected to reach USD 20.36 billion by 2033, growing at a CAGR of 7.40% from 2026 to 2033. This growth is primarily driven by increasing demand for minimally invasive aesthetic procedures, rising awareness of anti-aging and skin health benefits, a growing geriatric population with joint and ophthalmic care needs, and expanding applications in pharmaceuticals and cosmetics.

The hyaluronic acid market has been growing rapidly because of its expanding use in aesthetic medicine and cosmetic treatments that consumers increasingly prefer over surgical options. More people are choosing minimally invasive injections to reduce wrinkles, restore facial volume, and improve hydration, because these treatments offer shorter recovery times and natural-looking results. In addition, social media and online platforms have amplified awareness of skincare ingredients, prompting consumers to seek products with proven efficacy. Dermatologists and plastic surgeons have also reported a rise in patient interest in hyaluronic acid injections, reinforcing clinicians' confidence in these procedures. For instance, in February 2025, the U.S. Food and Drug Administration approved two new injectable hyaluronic acid gels, Evolysse Form and Evolysse Smooth, marking a significant step forward in dermal filler availability and innovation.

Another reason the industry has grown is broader adoption in medical and therapeutic applications across healthcare, not just cosmetics. HA's natural moisture-retaining and lubricating properties make it valuable for joint care, ophthalmology, and wound healing, thereby increasing its use in clinics and hospitals. Aging populations in many countries have driven demand for HA in treatments that support joint comfort and mobility, while improvements in HA-based medical devices have attracted clinician interest. In addition, professional education and high-profile clinical conferences highlighted new clinical data on HA products, contributing to broader understanding and acceptance among specialists. For instance, in November 2025, Obagi Medical shared new clinical data on its hyaluronic acid injectables at the American Society for Dermatologic Surgery Annual Meeting, demonstrating ongoing research and clinical engagement with HA technologies.

Consumer awareness of skincare and joint health has contributed to market growth, as more individuals actively seek products and treatments that support long-term wellness and aesthetic goals. Digital trends, social media, and influencer-driven beauty education have helped normalize the use of hyaluronic acid in daily skincare routines, increasing adoption across diverse age groups. At the same time, the aging global population has driven greater clinical interest in hyaluronic acid for therapeutic applications related to mobility, pain management, and ocular health. Continuous innovations in product technology have improved formulation stability, delivery efficiency, and patient outcomes. Enhanced accessibility through wider distribution channels has further expanded market penetration. Collectively, these factors have encouraged established companies to expand their product portfolios and scale up manufacturing, supporting sustained market momentum.

Global Hyaluronic Acid Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global hyaluronic acid market report based on application and region:

• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Dermal Fillers
• Osteoarthritis
  • Single Injection
  • Three Injection
  • Five Injection
• Ophthalmic
• Vesicoureteral Reflux
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Application
• 1.3. Estimates and Forecast Timeline
• 1.4. Research Methodology
• 1.5. Information Procurement
  • 1.5.1. Purchased Database
  • 1.5.2. GVR's Internal Database
  • 1.5.3. Secondary Sources
  • 1.5.4. Primary Research
• 1.6. Information Analysis
  • 1.6.1. Data Analysis Models
• 1.7. Market Formulation & Data Visualization
• 1.8. Model Details
  • 1.8.1. Commodity Flow Analysis
• 1.9. List of Secondary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Hyaluronic Acid Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Business Environment Analysis
  • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
    • 3.3.1.1. Supplier Power
    • 3.3.1.2. Buyer Power
    • 3.3.1.3. Substitution Threat
    • 3.3.1.4. Threat of New Entrants
    • 3.3.1.5. Competitive Rivalry
  • 3.3.2. PESTLE Analysis
  • 3.3.3. Pipeline Analysis
  • 3.3.4. Patent Expiry Analysis
  • 3.3.5. Pricing Analysis

Chapter 4. Hyaluronic Acid Market: Application Business Analysis

• 4.1. Application Market Share, 2025 & 2033
• 4.2. Application Segment Dashboard
• 4.3. Market Size & Forecasts and Trend Analysis, by application, 2021 to 2033 (USD Million)
• 4.4. Dermal Fillers
  • 4.4.1. Dermal Fillers Market, 2021 - 2033 (USD Million)
• 4.5. Osteoarthritis
  • 4.5.1. Osteoarthritis Market, 2021 - 2033 (USD Million)
  • 4.5.2. Single Injection
    • 4.5.2.1. Single Injection Market, 2021 - 2033 (USD Million)
  • 4.5.3. Three Injection
    • 4.5.3.1. Three Injection Market, 2021 - 2033 (USD Million)
  • 4.5.4. Five Injection
    • 4.5.4.1. Five Injection Market, 2021 - 2033 (USD Million)
• 4.6. Ophthalmic
  • 4.6.1. Ophthalmic Market, 2021 - 2033 (USD Million)
• 4.7. Vesicoureteral Reflux
  • 4.7.1. Vesicoureteral Reflux Market, 2021 - 2033 (USD Million)

Chapter 5. Hyaluronic Acid Market: Regional Estimates & Trend Analysis

• 5.1. Regional Market Share Analysis, 2025 & 2033
• 5.2. Regional Market Dashboard
• 5.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
• 5.4. North America
  • 5.4.1. North America Hyaluronic Acid Market Estimates and Forecasts, By Country, 2021 - 2033 (USD Million)
  • 5.4.2. U.S.
    • 5.4.2.1. Key Country Dynamics
    • 5.4.2.2. Application Disease Prevalence
    • 5.4.2.3. Regulatory Framework
    • 5.4.2.4. Reimbursement Framework
    • 5.4.2.5. U.S. Hyaluronic Acid Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4.3. Canada
    • 5.4.3.1. Key Country Dynamics
    • 5.4.3.2. Application Disease Prevalence
    • 5.4.3.3. Regulatory Framework
    • 5.4.3.4. Reimbursement Framework
    • 5.4.3.5. U.S. Hyaluronic Acid Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4.4. Mexico
    • 5.4.4.1. Key Country Dynamics
    • 5.4.4.2. Application Disease Prevalence
    • 5.4.4.3. Regulatory Framework
    • 5.4.4.4. Reimbursement Framework
    • 5.4.4.5. Mexico Hyaluronic Acid Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.5. Europe
  • 5.5.1. Europe Hyaluronic Acid Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5.2. UK
    • 5.5.2.1. Key Country Dynamics
    • 5.5.2.2. Application Disease Prevalence
    • 5.5.2.3. Regulatory Framework
    • 5.5.2.4. Reimbursement Framework
    • 5.5.2.5. UK Hyaluronic Acid Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5.3. Germany
    • 5.5.3.1. Key Country Dynamics
    • 5.5.3.2. Application Disease Prevalence
    • 5.5.3.3. Regulatory Framework
    • 5.5.3.4. Reimbursement Framework
    • 5.5.3.5. Germany Hyaluronic Acid Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5.4. France
    • 5.5.4.1. Key Country Dynamics
    • 5.5.4.2. Application Disease Prevalence
    • 5.5.4.3. Regulatory Framework
    • 5.5.4.4. Reimbursement Framework
    • 5.5.4.5. France Hyaluronic Acid Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5.5. Italy
    • 5.5.5.1. Key Country Dynamics
    • 5.5.5.2. Application Disease Prevalence
    • 5.5.5.3. Regulatory Framework
    • 5.5.5.4. Reimbursement Framework
    • 5.5.5.5. Italy Hyaluronic Acid Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5.6. Spain
    • 5.5.6.1. Key Country Dynamics
    • 5.5.6.2. Application Disease Prevalence
    • 5.5.6.3. Regulatory Framework
    • 5.5.6.4. Reimbursement Framework
    • 5.5.6.5. Spain Hyaluronic Acid Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5.7. Denmark
    • 5.5.7.1. Key Country Dynamics
    • 5.5.7.2. Application Disease Prevalence
    • 5.5.7.3. Regulatory Framework
    • 5.5.7.4. Reimbursement Framework
    • 5.5.7.5. Denmark Hyaluronic Acid Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5.8. Sweden
    • 5.5.8.1. Key Country Dynamics
    • 5.5.8.2. Application Disease Prevalence
    • 5.5.8.3. Regulatory Framework
    • 5.5.8.4. Reimbursement Framework
    • 5.5.8.5. Sweden Hyaluronic Acid Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5.9. Norway
    • 5.5.9.1. Key Country Dynamics
    • 5.5.9.2. Application Disease Prevalence
    • 5.5.9.3. Regulatory Framework
    • 5.5.9.4. Reimbursement Framework
    • 5.5.9.5. Norway Hyaluronic Acid Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.6. Asia Pacific
  • 5.6.1. Asia Pacific Hyaluronic Acid Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6.2. Japan
    • 5.6.2.1. Key Country Dynamics
    • 5.6.2.2. Application Disease Prevalence
    • 5.6.2.3. Regulatory Framework
    • 5.6.2.4. Reimbursement Framework
    • 5.6.2.5. Japan Hyaluronic Acid Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6.3. China
    • 5.6.3.1. Key Country Dynamics
    • 5.6.3.2. Application Disease Prevalence
    • 5.6.3.3. Regulatory Framework
    • 5.6.3.4. Reimbursement Framework
    • 5.6.3.5. China Hyaluronic Acid Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6.4. India
    • 5.6.4.1. Key Country Dynamics
    • 5.6.4.2. Application Disease Prevalence
    • 5.6.4.3. Regulatory Framework
    • 5.6.4.4. Reimbursement Framework
    • 5.6.4.5. India Hyaluronic Acid Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6.5. Australia
    • 5.6.5.1. Key Country Dynamics
    • 5.6.5.2. Application Disease Prevalence
    • 5.6.5.3. Regulatory Framework
    • 5.6.5.4. Reimbursement Framework
    • 5.6.5.5. Australia Hyaluronic Acid Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6.6. South Korea
    • 5.6.6.1. Key Country Dynamics
    • 5.6.6.2. Application Disease Prevalence
    • 5.6.6.3. Regulatory Framework
    • 5.6.6.4. Reimbursement Framework
    • 5.6.6.5. South Korea Hyaluronic Acid Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6.7. Thailand
    • 5.6.7.1. Key Country Dynamics
    • 5.6.7.2. Application Disease Prevalence
    • 5.6.7.3. Regulatory Framework
    • 5.6.7.4. Reimbursement Framework
    • 5.6.7.5. Thailand Hyaluronic Acid Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.7. Latin America
  • 5.7.1. Latin America Hyaluronic Acid Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7.2. Brazil
    • 5.7.2.1. Key Country Dynamics
    • 5.7.2.2. Application Disease Prevalence
    • 5.7.2.3. Regulatory Framework
    • 5.7.2.4. Reimbursement Framework
    • 5.7.2.5. Japan Hyaluronic Acid Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7.3. Argentina
    • 5.7.3.1. Key Country Dynamics
    • 5.7.3.2. Application Disease Prevalence
    • 5.7.3.3. Regulatory Framework
    • 5.7.3.4. Reimbursement Framework
    • 5.7.3.5. China Hyaluronic Acid Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.8. Middle East and Africa
  • 5.8.1. Middle East and Africa Hyaluronic Acid Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.8.2. South Africa
    • 5.8.2.1. Key Country Dynamics
    • 5.8.2.2. Application Disease Prevalence
    • 5.8.2.3. Regulatory Framework
    • 5.8.2.4. Reimbursement Framework
    • 5.8.2.5. South Africa Hyaluronic Acid Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.8.3. Saudi Arabia
    • 5.8.3.1. Key Country Dynamics
    • 5.8.3.2. Application Disease Prevalence
    • 5.8.3.3. Regulatory Framework
    • 5.8.3.4. Reimbursement Framework
    • 5.8.3.5. Saudi Arabia Hyaluronic Acid Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.8.4. UAE
    • 5.8.4.1. Key Country Dynamics
    • 5.8.4.2. Application Disease Prevalence
    • 5.8.4.3. Regulatory Framework
    • 5.8.4.4. Reimbursement Framework
    • 5.8.4.5. UAE Hyaluronic Acid Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.8.5. Kuwait
    • 5.8.5.1. Key Country Dynamics
    • 5.8.5.2. Application Disease Prevalence
    • 5.8.5.3. Regulatory Framework
    • 5.8.5.4. Reimbursement Framework
    • 5.8.5.5. Kuwait Hyaluronic Acid Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Competitive Landscape

• 6.1. Participant Overview
• 6.2. Company Market Position Analysis
• 6.3. Company Categorization
• 6.4. Strategy Mapping
• 6.5. Company Profiles/Listing
  • 6.5.1. Allergan
    • 6.5.1.1. Overview
    • 6.5.1.2. Financial Performance
    • 6.5.1.3. Product Benchmarking
    • 6.5.1.4. Strategic Initiatives
  • 6.5.2. Sanofi
    • 6.5.2.1. Overview
    • 6.5.2.2. Financial Performance
    • 6.5.2.3. Product Benchmarking
    • 6.5.2.4. Strategic Initiatives
  • 6.5.3. Genzyme Corporation
    • 6.5.3.1. Overview
    • 6.5.3.2. Financial Performance
    • 6.5.3.3. Product Benchmarking
    • 6.5.3.4. Strategic Initiatives
  • 6.5.4. Salix Pharmaceuticals
    • 6.5.4.1. Overview
    • 6.5.4.2. Financial Performance
    • 6.5.4.3. Product Benchmarking
    • 6.5.4.4. Strategic Initiatives
  • 6.5.5. F. Hoffmann-La Roche Ag
    • 6.5.5.1. Overview
    • 6.5.5.2. Financial Performance
    • 6.5.5.3. Product Benchmarking
    • 6.5.5.4. Strategic Initiatives
  • 6.5.6. Galderma Laboratories L.P.
    • 6.5.6.1. Overview
    • 6.5.6.2. Financial Performance
    • 6.5.6.3. Product Benchmarking
    • 6.5.6.4. Strategic Initiatives
  • 6.5.7. Zimmer Biomet
    • 6.5.7.1. Overview
    • 6.5.7.2. Financial Performance
    • 6.5.7.3. Product Benchmarking
    • 6.5.7.4. Strategic Initiatives
  • 6.5.8. Smith & Nephew Plc
    • 6.5.8.1. Overview
    • 6.5.8.2. Financial Performance
    • 6.5.8.3. Product Benchmarking
    • 6.5.8.4. Strategic Initiatives
  • 6.5.9. Ferring B.V.
    • 6.5.9.1. Overview
    • 6.5.9.2. Financial Performance
    • 6.5.9.3. Product Benchmarking
    • 6.5.9.4. Strategic Initiatives
  • 6.5.10. Lifecore Biomedical, Llc
    • 6.5.10.1. Overview
    • 6.5.10.2. Financial Performance
    • 6.5.10.3. Product Benchmarking
    • 6.5.10.4. Strategic Initiatives
  • 6.5.11. HTL Biotechnology
    • 6.5.11.1. Overview
    • 6.5.11.2. Financial Performance
    • 6.5.11.3. Product Benchmarking
    • 6.5.11.4. Strategic Initiatives